NR4A1 and breast cancer: To identify negative regulators of CTC-mediated metastasis, we introduced a genome-wide CRISPR-i library into BRx-142 cells, a CTC-derived cell line generated from a blood sample of a patient with advanced, refractory hormone receptor-positive (HR+) breast cancer (3).